Download
https://www.ndtvprofit.com/research-reports/glenmark-pharma-q3-results-review-margin-recovery-hinges-on-key-launches-cost-control-icici-direct?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Glenmarkâs numbers were in line with our expectations in terms of revenues but was a miss on operational front.
Share